Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Jagged1 is a cell surface ligand that plays a crucial role in the Notch signaling pathway. It is involved in cell fate determination, development, and tissue homeostasis. Aberrant expression or mutations in JAG1 are associated with diseases like Alagille syndrome and various cancers. The protein is composed of extracellular EGF-like repeats, a DSL domain, and a cysteine-rich region, and its interaction with Notch receptors initiates a cascade of signaling events that affect gene transcription.
Notch signaling pathway modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Jagged Canonical Notch Ligand 1 (JAG1).